Diabetes Pharmacotherapies and Bladder Cancer: A Medicare Epidemiologic Study

OBJECTIVE: Patients with type II diabetes have an increased risk of bladder cancer and are commonly treated with thiazolidinediones and angiotensin receptor blockers (ARBs), which have been linked to cancer risk. We explored the relationship between use of one or both of these medication types and i...

Descripción completa

Detalles Bibliográficos
Autores principales: Mackenzie, Todd A., Zaha, Rebecca, Smith, Jeremy, Karagas, Margaret R., Morden, Nancy E.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2016
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801809/
https://www.ncbi.nlm.nih.gov/pubmed/26894755
http://dx.doi.org/10.1007/s13300-016-0152-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4801809/
https://www.ncbi.nlm.nih.gov/pubmed/26894755
http://dx.doi.org/10.1007/s13300-016-0152-4

Ejemplares similares